1887
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-79-6-1323
1998-06-01
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jgv/79/6/9634072.html?itemId=/content/journal/jgv/10.1099/0022-1317-79-6-1323&mimeType=html&fmt=ahah

References

  1. Abbas A. K., Murphy K. M., Sher A. 1996; Functional diversity of helper T lymphocytes. Nature 383:787–793
    [Google Scholar]
  2. Ahn K., Angulo A., Ghazal P., Peterson P. A., Yang Y., Früh K. 1996; Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proceedings of the National Academy of Sciences, USA 93:10990–10995
    [Google Scholar]
  3. Ahn K., Gruhler A., Galocha B., Jones T. R., Wiertz E. J. H. J., Ploegh H. L., Peterson P. A., Yang Y., Früh K. 1997; The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6:613–621
    [Google Scholar]
  4. Aiken C., Konner J., Landau N. R., Lenburg M. E., Trono D. 1994; Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853–864
    [Google Scholar]
  5. Aitken A., Collinge D. B., van Heusden P. H., Isobe T., Roseboom P. H., Rosenfeld G., Soll J. 1992; 14-3-3 proteins : a highly conserved, widespread family of eukaryotic proteins. Trends in Biochemical Science 17:498–501
    [Google Scholar]
  6. Albrecht J.-C., Fleckenstein B. 1992; New member of the multigene family of complement control proteins in herpesvirus saimiri. Journal of Virology 66:3937–3940
    [Google Scholar]
  7. Alcamí A., Smith G. L. 1992; A soluble receptor for interleukin-1-β encoded by vaccinia virus. Cell 71:153–167
    [Google Scholar]
  8. Alcamí A., Smith G. L. 1995; Vaccinia, cowpox and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. Journal of Virology 69:4633–4639
    [Google Scholar]
  9. Alcamí A., Smith G. L. 1996; A mechanism for the inhibition of fever by a virus. Proceedings of the National Academy of Sciences, USA 93:11029–11034
    [Google Scholar]
  10. Antoni B. A., Sabbatini P., Rabson A. B., White E. 1995; Inhibition of apoptosis in human immunodeficiency virus-infected cells enhances virus production and facilitates persistent infection. Journal of Virology 69:2384–2392
    [Google Scholar]
  11. Arvanitakis L., Geras-raaka E., Varma A., Gershengorn M. C., Cesaman E. 1997; Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature 385:347–350
    [Google Scholar]
  12. Bauerle P. A., Baltimore D. 1996; NF- k B: ten years after. Cell 87:13–20
    [Google Scholar]
  13. Beck S., Barrel B. G. 1988; Human cytomegalovirus encodes a glycoprotein homologous to MHC class I antigens. Nature 331:269–272
    [Google Scholar]
  14. Beg A. A., Baldwin A. S. Jr 1993; The IκB proteins: multifunctional regulators of Rel/NF-KB transcription factors. Genes & Development 7:2064–2070
    [Google Scholar]
  15. Bell S., Cranage M., Borysiewicz L., Minson T. 1990; Induction of immunoglobulin G Fc receptors by recombinant vaccinia viruses expressing glycoproteins E and I of herpes simplex virus type 1. Journal of Virology 64:2181–2186
    [Google Scholar]
  16. Benn J., Schneider R. J. 1994; Hepatitis B virus Hbx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proceedings of the National Academy of SciencesUSA 91:10350–10354
    [Google Scholar]
  17. Benn J., Su F., Doria M., Schneider R. J. 1996; Hepatitis B virus Hbx protein induces transcription factor AP-1 by activation of extracellular signal-regulated and c-Jun N-terminal mitogen-activated protein kinases. Journal of Virology 70:4978–4985
    [Google Scholar]
  18. Bertin J., Armstrong R. C., Ottilie S., Martin D. A., Wang Y., Banks S., Wang G.-H., Senkevich T. G., Alnemri E. S., Moss B., Lenardo M. J., Tomaselli K. J., Cohen J. J. 1997; .containing herpesvirus and poxvirus proteins inhibit Fas-and TNFR1-induced apoptosis. Proceedings of the National Academy of Sciences, USA 94:1172–1176
    [Google Scholar]
  19. Bhattacharya S., Eckner R., Grossman S., Oldread E., Arany Z., D’Andrea A., Livingston D. M. 1996; Cooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha. Nature 383:344–347
    [Google Scholar]
  20. Biesinger A. L., Tsygankov A. Y., Fickenscher H., Emrich F., Fleckenstein B., Bolen J., Bröker B. M. 1995; The product of the herpesvirus saimiri ORF1 (tip) interacts with T cell specific kinase p56 Lck in transformed cells. Journal of Biological Chemistry 270:4729–4734
    [Google Scholar]
  21. Biron C. A. 1997; Activation and function of natural killer cell responses during viral infection. Current Opinion in Immunology 9:24–34
    [Google Scholar]
  22. Bishop J. M. 1991; Molecular themes in oncogenesis. Cell 64:235–248
    [Google Scholar]
  23. Borowski P., Heiland M., Oehlmann K., Becker B., Kornetzky L., Feucht H., Laufs H. 1996; Non-structural protein 3 of hepatitis C virus inhibits phosphorylation mediated by cAMP-dependent protein kinase. European Journal of Biochemistry 237:611–618
    [Google Scholar]
  24. Braselmann S., McCormick F. 1995; Bcr and Raf-1 form complex in vivo via 14–3–3 proteins. EMBO Journal 14:4839–4848
    [Google Scholar]
  25. Brockhaus K., Plaza S., Pintel D. J., Rommelaere J., Salomé N. 1996; Nonstructural proteins NS2 of minute virus of mice associate in vivo with 14–3–3 protein family members. Journal of Virology 70:7527–7534
    [Google Scholar]
  26. Brown J. B., Twardzik D. R., Marquardt H., Todaro G. I. 1985; Vaccinia virus encodes a polypeptide homologous to epidermal growth factor and transforming growth factor. Nature 313:491–492
    [Google Scholar]
  27. Buller R. M. L., Chakrabarti S., Cooper J. A., Twardzik D. R., Moss B. 1988; Deletion of the vaccinia virus growth factor gene reduces virus virulence. Journal of Virology 62:866–874
    [Google Scholar]
  28. Burgert H.-G., Kvist S. 1985; An adenovirus type 2 glycoprotein blocks cell surface expression ofhuman histocompatibility class I antigens. Cell 41:987–997
    [Google Scholar]
  29. Campbell A. E., Slater J. S. 1994; Down-regulation of major histocompatibility complex class I synthesis by murine cytomegalovirus early gene expression. Journal of Virology 68:1805–1811
    [Google Scholar]
  30. Campbell K. S., Ogris E., Burke B., Su W., Auger R., Druker B. J., Schaffhausen B. S., Roberts T. M., Pallas D. C. 1994; Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proceedings of the National Academy of Sciences, USA 91:6344–6348
    [Google Scholar]
  31. Carlin C. R., Tollefson A. E., Brady H. A., Hoffman B. L., Wold W. S. M. 1989; Epidermal growth factor receptor is down-regulated by a 10400 MW protein encoded by E3 region of adenovirus. Cell 57:135–144
    [Google Scholar]
  32. Cesarman E., Nador G., Bai F., Bohenzky R. A., Russo J. J., Moore P. S., Chang Y., Knowles D. M. 1996; Kaposi’s sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi’s sarcoma and malignant lymphoma. Journal of Virology 70:8218–8223
    [Google Scholar]
  33. Chee M. S., Satchwell S. C., Preddie E., Weston K. M., Barrell B. G. 1990; Human cytomegalovirus encodes three G protein coupled receptor homologues. Nature 344:774–777
    [Google Scholar]
  34. Chirillo P., Falco M., Puri P. L., Artini M., Balsano C., Levrero M., Natoli G. 1996; Hepatitis virus pX activates NF- k B dependent transcription through a Raf-independent pathway. Journal of Virology 70:641–646
    [Google Scholar]
  35. Colamonici O. R., Domanski P., Sweitzer S. M., Larner A., Buller R. M. L. 1995; Vaccinia virus B18R gene encodes a type I interferonbinding protein that blocks interferon α transmembrane signalling. Journal of Biological Chemistry 270:15974–15978
    [Google Scholar]
  36. Conklin D. S., Galaktionov K., Beach D. 1995; 14–33 proteins associate with cdc25 phosphatases. Proceedings of the National Academy of Sciences, USA 92:7892–7896
    [Google Scholar]
  37. Corbeil J., Tremblay M., Richman D. D. 1996; HIV-induced apoptosis requires the CD4 receptor cytoplasmic tail and is accelerated by interaction of CD4 with p56lck . Journal of Experimental Medicine 183:39–48
    [Google Scholar]
  38. Cowley S., Paterson H., Kemp P., Marshal C. J. 1994; Activation of MAP kinase is necessary and sufficient for PC12 differentiation and transformation of NIH 3T3 cells. Cell 77:841–852
    [Google Scholar]
  39. Coso O. A., Chiraiello M., Yu J. C., Teramoto H., Crespo P., Xu N., Miki T., Gutkind J. S. 1995; The small GTP-binding protein Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway. Cell 81:1137–1146
    [Google Scholar]
  40. Dahl J., Freund R., Blenis J., Benjamin T. L. 1996; Studies of partially transforming polyomavirus mutants establish a role for phosphatidylinositol 3-kinase in activation of pp70 S6 kinase. Molecular and Cellular Biology 16:2728–2735
    [Google Scholar]
  41. Darnell J. E. Jr Kerr I. M., Stark G. R. 1994; JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415–1421
    [Google Scholar]
  42. Deng H., Liu R., Ellmeier W., Choe S., Unutmaz D., Burkhart M., DiMarzio P., Marmon S., Sutton E., Hill C. M., Davis C., Peiper S. C., Schall T. J., Littman D. R., Landau N. R. 1996; Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661–665
    [Google Scholar]
  43. Dilworth S. M., Brewster C. E., Jones M. D., Lanfrancone L., Pelicci G., Pelicci G. 1994; Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc. Nature 367:87–90
    [Google Scholar]
  44. Dimitrov T., Krajcsi P., Hermiston T. W., Tollefson A. E., Hannink M., Wold W. S. M. 1997; Adenovirus E3-10.4/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes. Journal of Virology 71:2830–2837
    [Google Scholar]
  45. Dobbelstein M., Shenk T. 1996; Protection against apoptosis by the vaccinia virus SPI-2 (B13R) gene product. Journal of Virology 70:6479–6485
    [Google Scholar]
  46. Dunant N. M., Senften M., Ballmer-Hofer K. 1996; Polyomavirus middle-T antigen associates with the kinase domain of Src-related kinases. Journal of Virology 70:1323–1330
    [Google Scholar]
  47. Farrell H. E., Vally H., Lynch D. M., Fleming P., Shellam G. R., Scalzo A. A., Davis-Poynter N. J. 1997; Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo . Nature 386:510–514
    [Google Scholar]
  48. Feng Y., Broder C. C., Kennedy P. E., Berger E. A. 1996; HIV-1 entry cofactor: functional cDNA cloning of seven-transmembrane, G protein-coupled receptor. Science 272:872–876
    [Google Scholar]
  49. Fernandes R. S., McGowan A. J., Cotter T. G. 1996; Mutant H-ras overexpression inhibits drug and UV induced apoptosis. Anticancer Research 16:1691–1705
    [Google Scholar]
  50. Fleming S. B., McCaughan C. A., Andrews A. E., Nash A. D., Mercer A. A. 1997; A homolog of interleukin-10 is encoded by the poxvirus orf virus. Journal of Virology 71:4857–4861
    [Google Scholar]
  51. Foster G. R., Ackrill A. M., Goldin R. D., Kerr I. M., Thomas H. C., Stark G. R. 1991; Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons a and y and double-stranded RNA. Proceedings of the National Academy of Sciences, USA 88:2888–2892
    [Google Scholar]
  52. Freund R., Sotnikov A., Bronson R. T., Benjamin T. L. 1992; Polyoma virus middle T is essential for virus replication and persistence as well as for tumor induction in mice. Virology 191:716–723
    [Google Scholar]
  53. Frost J. A., Alberts A. S., Sontag E., Guan K., Mumby M. C., Feramisco J. R. 1993; Simian virus small t antigen cooperates with mitogen activated kinases to stimulate AP-1 activity. Molecular and Cellular Biology 14:6244–6252
    [Google Scholar]
  54. Fruehling S., Lee S. K., Herrold R., Frech B., Laux G., Kremmer E., Grasser F., Longnecker R. 1996; Identification of latent membrane protein 2A (LMP2A) domains essential for the dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. Journal of Virology 70:6216–6226
    [Google Scholar]
  55. Fu H., Xia K., Pallas D. C., Cui C., Conroy K., Narsimhan R. P., Mamon H., Colier R. J., Roberts T. M. 1994; Interaction of the protein kinase raf-1 with 14–3–3 proteins. Science 266:126–129
    [Google Scholar]
  56. Garcia J. V., Miller A. D. 1991; Serine phosphorylation independent down-regulation of cell-surface CD4 by nef. Nature 350:508–511
    [Google Scholar]
  57. Gerard C., Bao L., Orozco O., Pearson M., Kunz D., Gerard N. P. 1992; Molecular cloning of the mouse C5a anaphylatoxin receptor. Journal of Immunology 149:2600–2606
    [Google Scholar]
  58. Gompels U. A., Nicholas J., Lawrence G., Jones M., Thomson B. J., Martin M. E. 1995; The DNA sequence of human herpesvirus-6 : structure, coding content and genome evolution. Virology 209:29–51
    [Google Scholar]
  59. Good L., Sun S.-C. 1996; Persistent activation of NF-KB/Rel by human T-cell leukemia virus type 1 Tax involves degradation of I κBA. Journal of Virology 70:2730–2735
    [Google Scholar]
  60. Gougeon M.-L., Montagnier L. 1993; Apoptosis in AIDS. Science 260:1269–1270
    [Google Scholar]
  61. Greenway A. L., Azad A., McPhee D. A. 1995; Human immunodeficiency virus type 1 nef protein inhibits activation pathways in peripheral blood mononuclear cells and T cell lines. Journal of Virology 69:1842–1850
    [Google Scholar]
  62. Greenway A., Azad A., Mills J., McPhee D. 1996; Human immunodeficiency virus type 1 nef binds directly to Lck and mitogen-activated protein kinase, inhibiting kinase activity. Journal of Virology 70:6701–6708
    [Google Scholar]
  63. Han J., Sabbatini P., Perez D., Rao L., Modha D., White E. 1996; The E1B 19K protein blocks apoptosis by interacting with and inhibiting p-53 inducible death-promoting Bax protein. Genes & Development 10:461–477
    [Google Scholar]
  64. Harris S. L., Frank I., Cohen G. H., Eisenberg R. J., Friedman H. M. 1990; Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization. Journal of Infectious Diseases 162:331–337
    [Google Scholar]
  65. Hayakawa M., Ishida N., Takeuchi K., Shibamoto S., Hori T., Oku N., Ito F., Tsujimoto M. 1993; Arachidonic acid selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. Journal of Biological Chemistry 268:11290–11295
    [Google Scholar]
  66. Hengel H., Koopmann J.-O., Flohr T., Muranyi W., Goulmy E., Hämmerling G. J., Koszinowski U. H., Momburg F. 1997; A viral ER-resident glycoprotein inactivates the MHC-encoded peptide trans-porter. Immunity 6:623–632
    [Google Scholar]
  67. Hermiston T. W., Tripp R. A., Sparer T., Gooding L. R., Wold W. S. M. 1993; Deletion mutant analysis of the adenovirus type 2 E3-gp 19K protein: identification of sequences within the endoplasmic reticulum lumenal domain that are required for class I antigen binding and protection from adenovirus-specific cytotoxic T lymphocytes. Journal of Virology 67:5289–5298
    [Google Scholar]
  68. Herrero J. A., Mathew P., Paya C. V. 1995; LMP-1 activates NF-KB by targeting the inhibitory molecule I κBα. Journal of Virology 69:2168–2174
    [Google Scholar]
  69. Hirai H., Suzuki T., Fujisawa J.-I., Inoue J.-I., Yoshida M. 1994; .Tax protein of human T-cell leukemia virus type 1 binds to the ankyrin motifs of inhibitory factor K B and induces nuclear translocation of transcription factor NFF- K B proteins for transcriptional activation. Proceedings of the National Academy of Sciences, USA 91:3584–3588
    [Google Scholar]
  70. Hsu D.-H., de Waal Malefyt R., Fiorentino D. F. 1990; Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. Science 250:830–832
    [Google Scholar]
  71. Hu F. Q., Smith C. A., Pickup D. J. 1994; Cowpox virus contains two copies of an early gene encoding a soluble form of the type II TNF receptor. Virology 204:343–356
    [Google Scholar]
  72. Irvine R. 1996; Taking stock of PI-PLC. Nature 380:581–583
    [Google Scholar]
  73. Johnson R., Spiegelman B., Hanahan D., Wisdom R. 1996; Cellular transformation and malignancy induced by ras require c-jun. Molecular and Cellular Biology 16:4504–4511
    [Google Scholar]
  74. Jones T. R., Sun L. 1997; Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. Journal of Virology 71:2970–2979
    [Google Scholar]
  75. Jung J. U., Desrosiers R. C. 1995; Association of viral oncoprotein STP-C488 with cellularras. Molecular and Cellular Biology 15:6506–6512
    [Google Scholar]
  76. Jung J. U., Trimble J. J., King N. W., Biesinger B., Fleckenstein B. W., Desrosiers R. C. 1991; Identification of transforming genes of subgroup A and C strains of herpesvirus saimiri. Proceedings ofthe National Academy of Sciences, USA 88:7051–7055
    [Google Scholar]
  77. Jung J. U., Lang S. M., Jun T., Roberts T. M., Veilette A., Desrosiers R. C. 1995a; Downregulation of Lck-mediated signal transduction by tip of herpesvirus saimiri. Journal of Virology 69:7814–7822
    [Google Scholar]
  78. Jung J. U., Lang S. M., Friedrich U., Jun T., Roberts T. M., Desrosiers R. C., Biesinger B. 1995b; Identification of lck-binding elements in tip of herpesvirus saimiri. Journal of Biological Chemistry 270:20660–20667
    [Google Scholar]
  79. Kanno T., Franzoso G., Siebenlist U. 1994; Human T-cell leukemia type I Tax protein-mediated activation of NF- k B from p100 (NF-KB2)-inhibited cytoplasmic reservoirs. Proceedings of the National Academy of Sciences, USA 9112634–12638
    [Google Scholar]
  80. Karp C. L., Wysocka M., Wahl L. M., Ahearn J. M., Cuomo P. J., Sherry B., Trincheri G., Griffin D. E. 1996; Mechanism of suppression of cell-mediated immunity by measles virus. Science 273:228–231
    [Google Scholar]
  81. Kärre K., Welsh M. 1997; Viral decoy vetoes killer cell. Nature 386:446–447
    [Google Scholar]
  82. Kawanishi M. 1996; Antiapoptotic function ofthe Epstein-Barr virus LMP1 and BHRF1 proteins. Nippon-Rinsho 54:1848–1854
    [Google Scholar]
  83. Kaye K. M., Devergne O., Harada J. N., Izumi K. M., Yalamanchili R., Kieff E., Mosialos G. 1996; Tumor necrosis factor receptor associated factor 2 is a mediator of NF- k B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proceedings of the National Academy of Sciences, USA 93:11085–11090
    [Google Scholar]
  84. Kekulé A. S., Lauer U., Weiss L., Luber B., Hofschneider P. H. 1993; Hepatitis B virus transactivator HBx uses a tumour promoter signalling pathway. Nature 361:742–745
    [Google Scholar]
  85. Kettle S., Alcamí A., Khanna A., Ehret R., Jassoy C., Smith G. L. 1997; Vaccinia virus serpin B13R (SPI-2): inhibition of interleukinconverting enzyme and protection of virus-infected cells from TNF-and Fas-mediated apoptosis. Journal of General Virology 78:677–685
    [Google Scholar]
  86. Kim H. S., Lee Y. H., Min D. S., Chang J.-S., Ryu S. H., Ahn B.-Y., Suh P.-G. 1995; Tyrosine phosphorylation of phospholipase C-γ1 by vaccinia virus growth factor. Virology 214:21–28
    [Google Scholar]
  87. King C., Cooper J. A., Moss B., Twardzik D. R. 1986; Vaccinia virus growth factor stimulates tyrosine protein kinase activity of A431 cell epidermal growth factor receptors. Molecular and Cellular Biology 6:332–336
    [Google Scholar]
  88. Kinoshita T., Yokota T., Arai K., Miyajima A. 1995; Suppression of apoptotic death in hematopoietic cells by signaling through the IL-3/GM-CSF receptors. EMBO Journal 14:266–275
    [Google Scholar]
  89. Kotwal G. J., Isaacs S. N., McKenzie R., Frank M. M., Moss B. 1990; Inhibition of the complement cascade by the major secretory protein of vaccinia virus. Science 250:827–830
    [Google Scholar]
  90. Krajcsi P., Dimitrov T., Hermiston T. W., Tollefson A. E., Ranheim T. S., VandePol S. B., Stephenson A. H., Wold W. S. M. 1996; The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid. Journal of Virology 70:4904–4913
    [Google Scholar]
  91. Kung H.-J., Liu J.-L. 1997; Retroviral oncogenesis. In Viral Pathogenesis pp 235–266 Nathanson N., Ahmed R., Gonzalez-Scarano F., Griffin D. E., Holmes K. V., Murphy F. A., Robinson H. L. Edited by Philadelphia: Lippincott-Raven;
    [Google Scholar]
  92. Kwok R. P., Laurance M. E., Lundblad J. R., Goldman P. S., Shih H., Connor L. M., Marriott S. J., Goodman R. H. 1996; Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature 380:642–646
    [Google Scholar]
  93. Lacoste J., Petropoulos L., Pépin N., Hiscott J. 1995; Constitutive phosphorylation and turnover of I k Bα in human T-cell leukemia virus type 1-infected and Tax-expressing T cells. Journal of Virology 69:564–59
    [Google Scholar]
  94. Lane H. A., Fernandez A., Lamb N. J., Benjamin T. L. 1993; p70S6K function is essential for G1 progression. Nature 363:170–172
    [Google Scholar]
  95. Leonard G. T., Sen G. C. 1996; Efects of adenovirus E1A protein on interferon signaling. Virology 224:25–33
    [Google Scholar]
  96. Li J. P., D’Andrea A., Lodish H. F., Baltimore D. 1990; Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor. Nature 343:762–764
    [Google Scholar]
  97. Li J. P., Ho H., Niu Q. T., Fang C. 1995a; Cell surface activation of erythropoietin receptor by Friend spleen focus-forming virus gp55. Journal of Virology 69:1714–1719
    [Google Scholar]
  98. Li S., Janosch P., Tanji M., Rosenfeld G. C., Waymire J. C., Mischak H., Kolch W., Sedivy J. M. 1995b; Regulation of Raf-1 kinase activity by the 14–3–3 family of proteins. EMBO Journal 14:685–696
    [Google Scholar]
  99. Lindholm P. F., Tamami M., Makowski J., Brady J. N. 1996; Human T-cell lymphotropic virus type 1 Tax1 activation of NF-KB: involvement of the protein kinase pathway. Journal of Virology 70:2525–2532
    [Google Scholar]
  100. Ljunggren H. G., Kärre K. 1990; In search ofthe ‘missing self’: MHC molecules and NK cell recognition. Immunology Today 11:237–244
    [Google Scholar]
  101. Macen J. L., Garner R. S., Musy P. Y., Brooks M. A., Turner P. C., Moyer R. W., McFadden G., Bleackley R. C. 1996; Differential inhibition of the Fas-and granule-mediated cytolysis pathways by the orthopoxvirus cytokine response modifier A/SPI-2 and SPI-1 protein. Proceedings of the National Academy of Sciences, USA 93:9108–9113
    [Google Scholar]
  102. Maggirwar S. B., Harhaj E., Sun S.-C. 1995; Activation of NF- k B/Rel by Tax involves degradation of HBa and is blocked by a proteosome inhibitor. Oncogene 11:99–998
    [Google Scholar]
  103. Mansour S. J., Matten W. T., Hermann A. S., Candia J. M., Rong S., Fukasawa K., Vande Woude G. F., Ahn N. G. 1994; Transformation of mammalian cells by constitutively active MAP kinase. Science 265:966–970
    [Google Scholar]
  104. Marshall C. J. 1995; Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular-signal regulated kinase activities. Cell 70:179–185
    [Google Scholar]
  105. Martin P., Vass W. C., Schiller J. T., Lowy D. R., Velu T. J. 1989; The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors. Cell 59:21–32
    [Google Scholar]
  106. Massung R. F., Jayarama V., Moyer R. W. 1993; DNA sequence analysis of conserved and unique regions of swinepox virus. Virology 197:511–528
    [Google Scholar]
  107. Maxwell A. P., Goldberg H. J., Tay A. H., Li Z. G., Arbus G. S., Skoreczki K. L. 1993; Epidermal growth factor and phorbol myristate acetate increase expression ofthe mRNA for cytosolic phospholipase A2 in glomerular mesangial cells. Biochemical Journal 295:763–766
    [Google Scholar]
  108. Medveczky M. M., Geck P., Sullivan J. L., Serbousek D., Djeu J., Medveczky P. G. 1993; IL-2 independent growth and cytotoxicity of herpesvirus saimiri-infected human CD8 cells and involvement of two open reading frame sequences of the virus. Virology 196:402–412
    [Google Scholar]
  109. Meyer M., Caselmann W. H., Schlüter V., Schreck R., Hofschneider P. H., Bauerle P. A. 1992; Hepatitis activation of NF- k B, selective inhibition by antioxidants and integral membrane localization. EMBO Journal 11:2991–3001
    [Google Scholar]
  110. Miller C. L., Lee J. H., Kieff E., Longnecker R. 1994; An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proceedings of the National Academy of Sciences, USA 91:772–776
    [Google Scholar]
  111. Miller C. L., Burckhardt A. I., Lee J. H., Stealey B., Longnecker R., Kieff E. 1995; Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effect on protein tyrosine kinases. Immunity 2:155–186
    [Google Scholar]
  112. Minden A., Lin A., Claret F. X., Abo A., Karin M. 1995; Selective activation of JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81:1147–1157
    [Google Scholar]
  113. Modeer T., Yucel-Lindberg T., linuma M., Lerner U. H., Andersson G. 1993; Epidermal growth factor potentiate interleukin 1 and tumor necrosis factor-induced prostaglandin biosynthesis in human gingival fibroblasts. Cytokine 5:198–204
    [Google Scholar]
  114. Mossmann K., Upton C., Buller R. M. L., McFadden G. 1995; .Species specificity of ectromelia virus and vaccinia interferon-y binding proteins. Virology 208:762–769
    [Google Scholar]
  115. Müller U., Steinhoff U., Reis L. F. L., Hemmi S., Pavlovic J., Zinkernagel R. M., Auget M. 1994; Functional role of type I and type II interferons in antiviral defense. Nature 264:1918–1921
    [Google Scholar]
  116. Murphy P. M. 1994; Molecular mimicry and the generation of host defense protein diversity. Cell 72:823–826
    [Google Scholar]
  117. Nagata S. 1997; Apoptosis death factor. Cell 88:355–365
    [Google Scholar]
  118. Natoli G., Avantaggiati M. L., Chirillo P., De-Marzio E., Collepardo D., Falco M., Balsano C., Levrero M. 1995; Modulation of intracellular signal transduction pathways by the hepatitis virus trans-activator pX. Journal of Hepatology 22:14–20
    [Google Scholar]
  119. Nava V. E., Cheng E. H.-Y., Veliuona M., Zou S., Clem L. J., Mayer M. L., Hardwick J. M. 1997; Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene. Journal of Virology 71:4118–4122
    [Google Scholar]
  120. Neilan J. G., Lu Z., Afonso C. L., Kutish G. F., Sussman M. D., Rock D. L. 1993; An African swine fever virus gene with similarity to the proto-oncogene bcl-2 and the Epstein-Barr virus gene BHRF1. Journal of Virology 67:4391–4394
    [Google Scholar]
  121. Nevins J. R. 1992; E2F : a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424–429
    [Google Scholar]
  122. Nevins J. R. 1994; Cell cycle targets of the DNA tumor viruses. Current Opinion in Genetics and Development 4:130–134
    [Google Scholar]
  123. Nicholas J., Cameron K. R., Honess R. W. 1992; Herpesvirus saimiri encodes homologues of G-protein couple receptors and cyclins. Nature 355:362–365
    [Google Scholar]
  124. Nishizuka Y. 1992; Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258:607–614
    [Google Scholar]
  125. Nunn M. F., Marsh J. W. 1996; Human immunodeficiency virus type 1 Nef associates with a member of the p21-activated kinase family. Journal of Virology 70:6157–6161
    [Google Scholar]
  126. Olson J., Bishop G. A., Grose C. 1997; Varicella-zoster virus Fc receptor gE glycoprotein : serine/threonine and tyrosine phos phorylation of monomeric and dimeric forms. Journal of Virology 71:110–119
    [Google Scholar]
  127. Oltvai Z. N., Milliman C. L., Korsmeyer S. J. 1993; Bcl-2 heterodimerizes in vivo with a conserved homologue, Bax, that accelerates programmed cell death. Cell 74:609–619
    [Google Scholar]
  128. Oyaizu N., Than S., McCloskey T. W., Pahwa S. 1995; Requirement of p56lck in T-cell receptor apoptosis and Fas-ligand induction in Jurkat cells. Biochemical and Biophysical Research Communications 213:994–1001
    [Google Scholar]
  129. Pääbo S., Weber F., Kampe O., Schaffner W., Peterson P. 1983; Association between transplantation antigens and a viral membrane protein synthesized from an expression vector. Cell 35:445–453
    [Google Scholar]
  130. Pages G., Lenormand P., L’Alemain G., Chambard J. C., Meloche S., Poyssegur J. 1993; Mitogen-activated protein kinases p42mapk and p44mp are required for fibroblast proliferation. Proceedings of the National Academy of Sciences, USA 90:8319–8323
    [Google Scholar]
  131. Pallas D. C., Fu H. F., Haehnel L. C., Weller W., Collier R. J., Roberts T. M. 1994; Association of polyoma middle tumor antigen with 14–3–3 proteins. Science 266:535–537
    [Google Scholar]
  132. Radvanyi L. G., Shi Y., Vaziri H., Sharma A., Dhala R., Mills G. B., Miller R. G. 1996; CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. Journal of Immunology 156:1788–1798
    [Google Scholar]
  133. Rawlinson W. D., Farrell H. E., Barrell B. G. 1996; Analysis of the complete DNA sequence of murine cytomegalovirus. Journal of Virology 70:8833–8849
    [Google Scholar]
  134. Ray C. A., Black R. A., Kronheim S. R. 1992; Viral inhibition of inflammation. Cell 69:597–604
    [Google Scholar]
  135. Roberge C. J., Poubelle P. E., Beaulieu A. D., Heitz D., Gosselin J. 1996; The IL-1 and IL-1 receptor antagonist (IL-1Ra) response of human neutrofils to EBV stimulation. Journal of Immunology 156:4884–4891
    [Google Scholar]
  136. Reinhard C., Fernandez A., Lamb N. J., Thomas G. 1994; Nuclear localization of p85s6k: functional requirement for entry into S phase. EMBO Journal 13:1557–1565
    [Google Scholar]
  137. Reyburn H. T., Mandelboim O., Valés-Goméz M., Davis D., Pazmany L., Strominger J. L. 1997; The class I homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386:514–517
    [Google Scholar]
  138. Rommelaere J., Cornelis J. J. 1991; Antineoplastic activity of parvoviruses. Journal of Virology Methods 33:233–251
    [Google Scholar]
  139. Rother R. P., Rollins S. A., Fodor W. L., Albrecht J. C., Setter E., Fleckenstein B., Squinto S. P. 1994; Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. Journal of Virology 68:730–737
    [Google Scholar]
  140. Ruscetti S. K., Janesch N. J., Chakroborti A., Sawyer S. T., Hankins W. D. 1990; Friend spleen focus forming virus induces factor independence in an erythropoetin-dependent erythroleukemia cell line. Journal of Virology 63:1057–1062
    [Google Scholar]
  141. Salomé N., van Hille B., Duponchel N., Meneguzzi G., Cuzin F., Romelaere J., Cornelis J. J. 1990; Sensitization of transformed rat cells to parvovirus MVMp is restricted to specific oncogenes. Oncogene 5:123–130
    [Google Scholar]
  142. Samuel C. E. 1991; Antiviral actions of interferon -interferon regulated cellular proteins and their surprisingly selective antiviral activities. Virology 183:1–11
    [Google Scholar]
  143. Sarid R., Sato T., Bohenzky R. A., Russo J. J., Chang Y. 1997; Kaposi’s sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue. Nature Medicine 3:293–298
    [Google Scholar]
  144. Schalkwijk C. G., van-der-Heijden M. A., Bunt G., Maas R., Tertoolen L. G., van Bergen-en-Henegouwen P. M., Verkleij A. J., van den Bosch H., Boonstra J. 1996; Maximal epidermal growth factor induced cytosolic phospholipase A2 activation in vivo requires phosphorylation followed by an increased intracellular calcium concentration. Biochemical Journal 313:91–96
    [Google Scholar]
  145. Schouten G. J., van der Eb A., Zantema A. 1995; Downregulation of MHC class I expression due to interference with p105-NF KB processing by Ad12E1A. EMBO Journal 14:1498–1507
    [Google Scholar]
  146. Schroter M., Lowin B., Borner C., Tschopp J. 1995; Regulation of Fas (Apo-1/CD95)-and perforin-mediated lytic pathway of primary cytotoxic T lymphocytes by the protooncogene bcl-2. European Journal of Immunology 25:3509–3513
    [Google Scholar]
  147. Schwartz O., Maréchal V., Le Gall S., Lemonnier F., Heard J.-M. 1996; Endocytosis of major histocompatibility complex class I molecules is induced by HIV-I Nef protein. Nature Medicine 2:338–342
    [Google Scholar]
  148. Semmes O. J., Barrett J. F., Dang C. V., Jeang K. T. 1996; Human T-cell leukemia virus type I tax masks c-Myc function through a cAMP-dependent pathway. Journal of Biological Chemistry 271:9730–9738
    [Google Scholar]
  149. Shadan F. F., Cowsert L. M., Villareal L. P. 1994; n-Butyrate, a cell cycle blocker, inhibits the replication of polyomaviruses and papillomaviruses but not that of adenoviruses and herpesviruses. Journal of Virology 68:4785–4796
    [Google Scholar]
  150. Shiroki K., Yamakawa A., Shibata M., Takenawa T., Sugano S., Nomoto A. 1992; Adenovirus E1A proteins stimulate inositol phospholipid metabolism in PC12 cells. Journal of Virology 66:6093–6098
    [Google Scholar]
  151. Smith G. L. 1994; Virus strategies for evasion of the host response to infection. Trends in Microbiology 8:81–88
    [Google Scholar]
  152. Smith C. A., Hu F. Q., Richards C. L., Smolak P., Goodwin R. G., Pickup D. J. 1996a; Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not LT alpha. Virology 223:132–147
    [Google Scholar]
  153. Smith B. L., Krushelnycky W., Mochly-Rosen D., Berg P. 1996b; The HIV Nef protein associates with protein kinase C theta. Journal of Biological Chemistry 271:16753–16757
    [Google Scholar]
  154. Sontag E., Fedorov S., Kamibayashi C., Robbins D., Cobb M., Mumby M. 1993; The interaction of SV40 small tumor antigen with protein phosphatase 2A stimulates the MAP kinase pathway and induces cell proliferation. Cell 75:887–897
    [Google Scholar]
  155. Spriggs M. K., Hruby D. E., Maliszewski C. R., Pickup D. J., Sims J. E., Buller R. M. L., VanSlyke J. 1992; Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein. Cell 71:145–152
    [Google Scholar]
  156. Su B., Jacinto E., Hibi M., Kallunki T., Karin M., Ben-Neriah Y. 1994; JNK is involved in signal integration during costimulation of T-lymphocytes. Cell 77:727–736
    [Google Scholar]
  157. Su W., Liu W., Schaffhausen B. S., Roberts T. M. 1995; Association of polyomavirus middle tumor antigen with phospholipase C-gamma 1. Journal of Biological Chemistry 270:12331–12334
    [Google Scholar]
  158. Su F., Schneider R. J. 1996; Hepatitis B virus Hbx protein activates transcription factor NF- k B by acting on multiple cytoplasmic inhibitors of rel-related proteins. Journal of Virology 70:4558–4566
    [Google Scholar]
  159. Symons J. A., Alcamí A., Smith G. L. 1995; Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell 81:551–560
    [Google Scholar]
  160. Tewari M., Dixit V. M. 1995; Fas-and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product. Journal of Biological Chemistry 270:3255–3260
    [Google Scholar]
  161. Tewari M., Telford W. G., Miller R. A., Dixit V. M. 1995; CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. Journal of Biological Chemistry 270:22705–22708
    [Google Scholar]
  162. Thale R., Lucin P., Schneider K., Eggers M., Koszinowski U. H. 1994; Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. Journal of Virology 68:7757–7765
    [Google Scholar]
  163. Thale R., Szepan U., Hengel H., Geginat G., Lucin P., Koszinowski U. H. 1995; Identification of the mouse cytomegalovirus genomic region affecting MHC class I molecule transport. Journal of Virology 69:6098–6105
    [Google Scholar]
  164. Thome M., Schneider P., Hofman K., Fickenscher H., Meinl E., Neipel E., Mattman C., Burns K., Bodmer J.-L., Schroter M. others 1997; Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517–521
    [Google Scholar]
  165. Toker A., Sellers L. A., Ames B., Patel Y., Harris H., Aitken A. 1992; Multiple isoforms of a protein kinase C inhibitor (KCIP-14–3–3) from sheep brain. Amino acid sequence of phosphorylated forms. European Journal of Biochemistry 206:453–461
    [Google Scholar]
  166. Tollefson A. E., Stewart A. R., Yei S., Saha S. K., Wold W. S. M. 1991; The 10400-and 14500-dalton proteins encoded by region E3 of adenovirus form a complex and function together to down-regulate the epidermal growth factor receptor. Journal of Virology 65:3095–3105
    [Google Scholar]
  167. Upton C., Macen J. L., Schreiber M., McFadden G. 1991; Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184:370–382
    [Google Scholar]
  168. Upton C., Mossman K., McFadden G. 1992; Encoding of a homolog of the IFN-γ receptor by myxoma virus. Science 258:1369–1372
    [Google Scholar]
  169. Varmus H. 1989; An historical overview of oncogenes. In Oncogenes and Molecular Origins of Cancer pp 3–44 Weinberg R. Edited by Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press;
    [Google Scholar]
  170. Vousden K. H. 1995; Regulat ion of cell cycle by viral oncoproteins. Seminars in Cancer Biology 6:109–116
    [Google Scholar]
  171. Wang H. G., Rapp U. R., Reed J. C. 1996; Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87:629–638
    [Google Scholar]
  172. Weiss A., Littman D. R. 1994; Signal transduction by lymphocyte antigen receptors. Cell 76:263–274
    [Google Scholar]
  173. Whitman M., Kaplan D. R., Schaffhausen B. S., Cantley L., Roberts T. M. 1985; Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature 315:239–242
    [Google Scholar]
  174. Wiertz E. J. H. J., Jones T. R., Sun L., Bogyo M., Geuze H. J., Ploegh H. L. 1996; The human cytomegalovirus US 11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84:769–779
    [Google Scholar]
  175. Wold W. S. M. 1993; Adenovirus genes that modulate the sensitivity of virus-infected cells to TNF. Journal of Cell Biochemistry 53:329–335
    [Google Scholar]
  176. Yao Z., Fanslow W. C., Seldin M. F., Rousseau A. M., Painter S. L., Comeau M. R., Cohen J. I., Spriggs M. K. 1995; Herpesvirus saimiri encodes a new cytokine IL-17, which binds to a novel cytokine receptor. Immunity 3:811–821
    [Google Scholar]
  177. York I. A., Roop C., Andrews D. W., Riddell S. R., Graham F. L., Johnson D. C. 1994; A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77:525–535
    [Google Scholar]
  178. Zauli G., Previati M., Caramelli E., Bassini A., Falcieri E., Gibellini D., Bertolaso L., Bosco D., Robuffo I., Capitani S. 1995; Exogenous human immunodeficiency virus type-1 Tat protein selectively stimulates a phosphatidylinositol-specific phospholipase C nuclear pathway in the Jurkat T cell line. European Journal of Immunology 25:2695–2700
    [Google Scholar]
  179. Zha J., Harada H., Yang E., Jockel J., Korsmeyer S. J. 1996; Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14–3–3 not BCL-XL . Cell 87:619–628
    [Google Scholar]
  180. Zhang J. J., Vinkemeier U., Gu W., Chakravarti D., Horvath C. M., Darnell J. E. Jr 1996; Two contact regions between Stat1 and CBP/p300 in interferon y signaling. Proceedings of the National Academy of Sciences, USA 93:15092–15096
    [Google Scholar]
  181. Ziegler H., Thale R., Lucin P., Muranyi W., Flohr T., Hengel H., Farrel H., Rawlinson W., Koszinowski U. H. 1997; A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. Immunity 6:57–66
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-79-6-1323
Loading
/content/journal/jgv/10.1099/0022-1317-79-6-1323
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error